Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials.

Objective: This study aimed to examine the impact of the COVID-19 pandemic on patients with serious mental illness (SMI), specifically relating to psychiatric morbidity, pandemic-induced stress, and ability to cope with pandemic-related precautionary measures, restrictions, and disruptions to daily...

Descripción completa

Detalles Bibliográficos
Publicado en:Innovations in Clinical Neuroscience Vol. 21; no. 1-3; pp. 13 - 19
Autores principales: GARCIA-RADA, MARIA FE, LITMAN, ROBERT E.
Formato: research tables/charts Journal Article
Publicado: Matrix Medical Communications, LLC Jan-Mar2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175951849&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 175951849
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        21588333
        DAD5
      jtl: Innovations in Clinical Neuroscience
      issn: 21588333
      maglogo: N
    pubinfo:
      dt: Jan-Mar2024
      vid: 21
      iid: 1-3
      pid: 33670
      pub: Matrix Medical Communications, LLC
      place: West Chester, Pennsylvania
    artinfo:
      ui:
        175951849
        175951849
        175951849
        175951849
      ppf: 13
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials.
      aug:
        au:
          GARCIA-RADA, MARIA FE
          LITMAN, ROBERT E.
        affil: CenExel CBH Health in Gaithersburg, Maryland
      sug:
        subj:
          COVID-19 Pandemic Psychosocial Factors
          COVID-19 Prevention and Control
          Stay-at-Home Orders Psychosocial Factors
          Mental Disorders Psychosocial Factors
          Research Subjects Psychosocial Factors
          Clinical Trials
          Stress, Psychological Evaluation
          Coping Evaluation
          Patient Attitudes Evaluation
          Life Experiences Evaluation
          Human
          Psychiatric Patients Psychosocial Factors
          United States
          Comparative Studies
          Univariate Statistics
          Unpaired T-Tests
          Analysis of Variance
          Descriptive Statistics
          Masks
          Social Distancing
          COVID-19 Vaccines Administration and Dosage
          Suicidal Ideation
          Health Resource Utilization
          Psychiatric Care Utilization
          Mental Disorders Symptoms
      ab: Objective: This study aimed to examine the impact of the COVID-19 pandemic on patients with serious mental illness (SMI), specifically relating to psychiatric morbidity, pandemic-induced stress, and ability to cope with pandemic-related precautionary measures, restrictions, and disruptions to daily life. Design: A cross-sectional survey study of 277 clinical trial patients was conducted. This sample included nonpsychiatric controls (n=139) and patients with a diagnosis of bipolar disorder, major depressive disorder (MDD), or schizophrenia (n=138) located at five clinical trial sites across the United States. A univariate analysis was performed to obtain general frequencies of the sample. Unpaired t-tests were used in comparing the groups on numerical variables, and analysis of variance (ANOVA) was performed to identify difierences when comparing three or more categories. Results: Patients with SMI were more likely to report wearing face masks, avoiding large gatherings, and endorsing the use of precautionary measures, despite receiving a COVID-19 vaccine (p<0.001). A total of 70.3 percent (n=97) of all patients with SMI reported experiencing at least one episode of symptom worsening, 48 percent reported experiencing suicidal ideation, and 66 percent reported a need for increased mental healthcare due to COVID-19-related distress. Patients with SMI reported higher levels of stress, compared to controls, with patients with MDD having the highest levels of stress (p<0.001). Conclusion: These findings demonstrate an increased vulnerability to symptom worsening in patients with SMI during a pandemic and suggest the need to account for pandemic-induced psychological stress in clinical trial design, subject selection, and symptoms ratings.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N